Electrically mediated delivery of vector plasmid DNA elicits an antitumor effect

In vivo electroporation is an efficient means of increasing plasmid DNA delivery to normal tissues, such as skin and muscle, as well as directly to tumors. In the experiments described here, plasmid DNA was delivered by in vivo electroporation to B16 mouse melanomas using two very different pulsing protocols. Reporter expression increased 21- or 42-fold, respectively with electroporation over injection alone. The growth of experimental melanomas with an approximate diameter of 4 mm on the day of treatment was monitored after electroporation delivery of reporter plasmid DNA. Remarkably, short-term complete regressions using one of these pulsing protocols occurred in up to 100% of mice. These regressions continued long term in up to 83% of animals. 70% of these mice were resistant to challenge with B16 melanoma cells. Histological analysis revealed large numbers of apoptotic cells 24 h after treatment. This antitumor effect did not require therapeutic cDNA expression or eukaryotic sequences.

[1]  M. Jaroszeski,et al.  Clinical applications of electrochemotherapy. , 1999, Advanced drug delivery reviews.

[2]  H. Aihara,et al.  Gene transfer into muscle by electroporation in vivo. , 1998, Nature biotechnology.

[3]  A. Brasier.  Reporter System Using Firefly Luciferase , 1990, Current protocols in molecular biology.

[4]  A. Benabid,et al.  Muscle transfection by electroporation with high-voltage and short-pulse currents provides high-level and long-lasting gene expression. , 2000, Human gene therapy.

[5]  M. Jaroszeski,et al.  Electrochemotherapy: an emerging drug delivery method for the treatment of cancer. , 1997, Advanced drug delivery reviews.

[6]  Y. Fujisawa,et al.  Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity. , 1984, Journal of the National Cancer Institute.

[7]  A. Bird.  CpG-rich islands and the function of DNA methylation , 1986, Nature.

[8]  L. Heller,et al.  Delivery of plasmid DNA by in vivo electroporation Review Article , 2004 .

[9]  T. Kurata,et al.  Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase. , 2000, Vaccine.

[10]  G. Bishop,et al.  CpG motifs in bacterial DNA trigger direct B-cell activation , 1995, Nature.

[11]  E. Kuramoto,et al.  In vitro Augmentation of Natural Killer Cell Activity and Production of Interferon‐α/β and ‐γ with Deoxyribonucleic Acid Fraction from Mycobacterium bovis BCG , 1988, Japanese journal of cancer research : Gann.

[12]  M. Bureau,et al.  High-efficiency gene transfer into skeletal muscle mediated by electric pulses. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[13]  M. Rols,et al.  In vivo electrically mediated protein and gene transfer in murine melanoma , 1998, Nature Biotechnology.

[14]  T. Nishi,et al.  Intratumoral delivery of interleukin 12 expression plasmids with in vivo electroporation is effective for colon and renal cancer. , 2001, Human gene therapy.

[15]  M. Jaroszeski,et al.  Intradermal delivery of interleukin-12 plasmid DNA by in vivo electroporation. , 2001, DNA and cell biology.

[16]  K. Wells,et al.  Inflammatory responses following direct injection of plasmid DNA into skeletal muscle , 1998, Gene Therapy.

[17]  M. Jaroszeski,et al.  Electrically mediated plasmid DNA delivery to hepatocellular carcinomas in vivo , 2000, Gene Therapy.

[18]  S. Sukharev,et al.  In vivo electroporation and stable transformation of skin cells of newborn mice by plasmid DNA. , 1991, Biochimica et biophysica acta.

[19]  G. Acsadi,et al.  Direct gene transfer into mouse muscle in vivo. , 1990, Science.

[20]  R. Malone,et al.  Efficient nonviral cutaneous transfection. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[21]  G. Hartmann,et al.  Mechanism of action of CpG DNA. , 2000, Current topics in microbiology and immunology.

[22]  R. Cortese,et al.  Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[23]  R. Malone,et al.  Cutaneous transfection and immune responses to intradermal nucleic acid vaccination are significantly enhanced by in vivo electropermeabilization. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[24]  T. Muramatsu,et al.  Foreign gene expression in the mouse testis by localized in vivo gene transfer. , 1997, Biochemical and biophysical research communications.

[25]  H. Hirai,et al.  In vivo electroporation-mediated transfer of interleukin-12 and interleukin-18 genes induces significant antitumor effects against melanoma in mice , 2001, Gene Therapy.

[26]  M. Jaroszeski,et al.  In vivo electroporation using an exponentially enhanced pulse: a new waveform. , 2001, DNA and cell biology.

[27]  G. Thai,et al.  Therapeutic tumor immunity induced by polyimmunization with melanoma antigens gp100 and TRP-2. , 2001, Cancer research.

[28]  J. Suen,et al.  Intramuscular electroporation delivery of IFN-α gene therapy for inhibition of tumor growth located at a distant site , 2001, Gene Therapy.

[29]  J. Kuratsu,et al.  High-efficiency in vivo gene transfer using intraarterial plasmid DNA injection following in vivo electroporation. , 1996, Cancer research.

[30]  G. Weiner,et al.  Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[31]  M J Jaroszeski,et al.  Novel electrode designs for electrochemotherapy. , 1997, Biochimica et biophysica acta.

[32]  R. Heller,et al.  Immunomodulation by electrically enhanced delivery of plasmid DNA encoding IL-12 to murine skeletal muscle. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[33]  S. Hui,et al.  Electroporation-enhanced gene delivery in mammary tumors , 2000, Gene Therapy.

[34]  G. Weiner,et al.  Immunostimulatory CpG oligodeoxynucleotides enhance the immune response to vaccine strategies involving granulocyte-macrophage colony-stimulating factor. , 1998, Blood.

[35]  J. Ulmer,et al.  Increased DNA Vaccine Delivery and Immunogenicity by Electroporation In Vivo , 2000, The Journal of Immunology.

[36]  I. Mathiesen.  Electropermeabilization of skeletal muscle enhances gene transfer in vivo , 1999, Gene Therapy.

[37]  T. Kurata,et al.  Protection against influenza virus infection in mice immunized by administration of hemagglutinin-expressing DNAs with electroporation. , 2000, Vaccine.

[38]  M. Jaroszeski,et al.  In vivo electroporation of plasmids encoding GM-CSF or interleukin-2 into existing B16 melanomas combined with electrochemotherapy induces long-term antitumour immunity , 2000, Melanoma research.

[39]  D. Liggitt,et al.  Lipid-DNA complexes induce potent activation of innate immune responses and antitumor activity when administered intravenously. , 1999, Journal of immunology.

[40]  Darius Moradpour,et al.  In vivo gene electroinjection and expression in rat liver , 1996, FEBS letters.

[41]  M. Jaroszeski,et al.  Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo. , 1999, Cancer research.

[42]  Toshiyuki Matsuzaki,et al.  Direct gene transfer into rat liver cells by in vivo electroporation , 1998, FEBS letters.

[43]  E. Raz,et al.  Immunostimulatory DNA Sequences Necessary for Effective Intradermal Gene Immunization , 1996, Science.

[44]  G. A. Hofmann,et al.  Highly efficient electro-gene therapy of solid tumor by using an expression plasmid for the herpes simplex virus thymidine kinase gene. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[45]  J. Miyazaki,et al.  Electroporation-mediated interleukin-12 gene therapy for hepatocellular carcinoma in the mice model. , 2001, Cancer research.

[46]  A. Folgori,et al.  Enhancing B- and T-Cell Immune Response to a Hepatitis C Virus E2 DNA Vaccine by Intramuscular Electrical Gene Transfer , 2000, Journal of Virology.

[47]  J. Miyazaki,et al.  Continuous erythropoietin delivery by muscle-targeted gene transfer using in vivo electroporation. , 2000, Human gene therapy.